In a recent interview with Fierce, Ostro co-founders Ahmed Elsayyad and Chase Feiger, M.D. shared how artificial intelligence is reshaping the pharma marketing landscape—from regulatory-compliant personalization to frictionless engagement for healthcare professionals (HCPs) and patients. Both executives bring medical and venture capital backgrounds to the table, positioning Ostro at the forefront of combining clinical insight with tech innovation. The pair emphasized the growing importance of AI councils in pharma and how successful integration depends on balancing speed, compliance and personalization.
Elsayyad and Feiger also discussed the shift from AI-driven execution to AI-powered engagement, where HCPs interact with approved content in real time, similar to how consumers use platforms like ChatGPT or Netflix. The future, they argue, lies in intuitive, adaptive experiences that anticipate user needs with minimal friction. To hear how Ostro is enabling real-time, compliant AI experiences—and what "Talk with AI before talk with your doctor" really means—watch the full video interview.
The editorial staff had no role in this post's creation.